Window Therapeutics is committed to discovering and developing transformational therapeutics to address critical unmet patient needs in cancer and other life-threatening diseases through the application of its proprietary Brush-Analogue Macromolecule (BAM) technology
Window Therapeutics is committed to discovering and developing transformational therapeutics to address critical unmet patient needs in cancer and other life-threatening diseases through the application of its proprietary Brush-Analogue Macromolecule (BAM) technology.